Navigation Links
Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
Date:8/7/2008

KOBE, Japan, Aug. 8 /PRNewswire/ -- Carna Biosciences, Inc. ("Carna") is pleased to announce the signing of a collaborative agreement with Caliper Life Sciences, Inc. USA ("Caliper") on August 6 (US Eastern Daylight Time). Carna will supply a set of discrete protein kinases aiding the expansion of Caliper's kinase profiling and assay development services, and ProfilerPro Kinase Selectivity Assay Kits. Caliper's products and services are widely used and highly regarded by leading pharmaceutical and biotech companies. The selection of Carna as a Preferred Provider enhances the visibility and use of Carna's products in the area of kinase inhibitor drug discovery -- a major focus of targeted therapy in the areas of cancer, neurological, and autoimmune diseases.

"I am proud of the expression and purification technologies that Carna has developed in order to produce nearly 300 human kinases to date, and even more pleased that Caliper has selected Carna Biosciences as a principle supplier for Caliper's ProfilerPro Kits," said Kohichiro Yoshino, President and CEO of Carna Biosciences. "Caliper is an established and reliable partner to the pharmaceutical and biotech industry.

Working with Caliper provides Carna with access to a wealth of new opportunities to expand sales of protein kinases throughout the worldwide market. This synergistic impact of combining Caliper's advanced instrumentation with the wide selection and premier quality reagents provided by Carna will greatly benefit both companies and their clients. We anticipate that this expanded relationship with Caliper will further position us to explore R&D Partnerships with global biopharmaceutical companies.

About Carna Biosciences, Inc.

Carna Biosciences, Inc. (http://www.carnabio.com), founded in April 2003, is a Japanese biotechnology company conducting intercellular signaling-based drug discovery programs, as well as providing drug discovery services to pharmaceutical companies, using proprietary technologies in gene cloning, active kinase protein expression, protein purification and homogeneous assay development.

The company provides products and services including protein kinases, profiling and screening services, assay development services and crystallography products and services.

About Caliper Life Sciences, Inc.

Caliper Life Sciences, Inc. (http://www.caliperls.com) is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions.

Contact:

Tomohisa Yamazaki,

Manager

Corporate Planning

Carna Biosciences, Inc.

Phone: +81-78-302-7039

Fax: +81-78-302-6665

E-mail: ir-team@carnabio.com

URL: http://www.carnabio.com


'/>"/>
SOURCE Carna Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
2. Pressure BioSciences, Inc. Announces the Market Release of its PCT-Enhanced Trypsin Digestion Application for Proteomics
3. Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
4. NOTICE OF YM BIOSCIENCES CONFERENCE CALL TO DISCUSS PHASE II DATA FOR NIMOTUZUMAB IN METASTATIC COLORECTAL CANCER
5. David J. Mazzo, Ph.D., Joins Regado Biosciences as President and CEO
6. Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors
7. Neurocrine Biosciences Reports Second Quarter 2008 Results
8. Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
9. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
10. Neurocrine Biosciences Announces Conference Call and Webcast To Present Second Quarter 2008 Financial Results
11. SuperArray Bioscience Changes Name to SABiosciences and Moves Into New Larger Facility on Verge of Tenth Anniversary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Mar 23, 2017 Research and Markets ... Markets" report to their offering. ... The Global Market for ... in 2016 at a CAGR of 8.9%, ... non-energetic bioproducts into seven major product segments: bio-derived chemicals, biofuels, ...
(Date:3/23/2017)... , March 23, 2017  SeraCare Life ... global in vitro diagnostics manufacturers and clinical ... industry,s first multiplexed Inherited Cancer reference ... by next-generation sequencing (NGS). The Seraseqâ„¢ Inherited ... with input from industry experts to validate ...
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... SEATTLE , March 23, 2017 ... translational development of novel therapies in immuno-oncology, today ... to lead" small molecule compounds that activate interferon ... (RLR) pathways and demonstrate immune-mediated tumor regression in ... in the study who demonstrated complete tumor regression ...
Breaking Biology Technology:
(Date:3/7/2017)... England , March 7, 2017 Brandwatch , ... chosen by The Prince,s Trust to uncover insights to ... across The Trust. The UK,s leading youth charity will ... social campaign results and get a better understanding of the topics ... ...
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
(Date:2/28/2017)... 2017   Acuant , a leading provider of ... enhancements to new and core technologies building upon the ... mobile and desktop Acuant FRM TM facial recognition ... real time manual review of identity documents by accredited ... fastest and most accurate capture software to streamline workflows ...
Breaking Biology News(10 mins):